Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase

被引:89
|
作者
Ashraf, Zaman [1 ,2 ]
Rafiq, Muhammad [1 ]
Seo, Sung-Yum [1 ]
Babar, Mustafeez Mujtaba [3 ]
Zaidi, Najam-us-Sahar Sadaf [3 ]
机构
[1] Kongju Natl Univ, Coll Nat Sci, Dept Biol, Kong Ju 314701, South Korea
[2] Allama Iqbal Open Univ, Dept Chem, Islamabad 44000, Pakistan
[3] Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci, Islamabad 44000, Pakistan
关键词
Vanillin derivatives; Synthesis; Mushroom tyrosinase inhibitors; Kinetic mechanism; In silico docking; DOPAMINE; RECEPTOR;
D O I
10.1016/j.bmc.2015.06.068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the present study was to discover the extent of contribution to antityrosinase activity by adding hydroxy substituted benzoic acid, cinnamic acid and piperazine residues to vanillin. The study showed the transformation of vanillin into esters as shown in (4a-4d), (6a-6b), and (8a-8b). In addition, the relationship between structures of these esters and their mushroom tyrosinase inhibitory activity was explored. The kinetics of inhibition on mushroom tyrosinase by these esters was also investigated. It was found that hydroxyl substituted benzoic acid derivatives were weak inhibitors; however hydroxy or chloro substituted cinnamic acid and piperazine substituted derivatives were able to induce significant tyrosinase inhibition. The mushroom tyrosinase (PDBID 2ZWE) was docked with synthesized vanillin derivatives and their calculated binding energies were compared with experimental IC50 values which provided positive correlation. The most potent derivative 2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate (6a) possesses hydroxy substituted cinnamic acid scaffold having IC50 value 16.13 mu M with binding energy of -7.2 kcal/mol. The tyrosinase inhibitory activity of (6a) is comparable with standard kojic acid. Kinetic analysis indicated that compound 6a was mixed-type tyrosinase inhibitor with inhibition constant values K-i (13 mu M) and K-i' (53 mu M) and formed reversible enzyme inhibitor complex. The active vanillin analog (6a) was devoid of toxic effects as shown in cytotoxic studies. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5870 / 5880
页数:11
相关论文
共 50 条
  • [41] Synthesis and biological evaluation of helicid analogues as mushroom tyrosinase inhibitors
    Yi, Wei
    Cao, Rihui
    Wen, Huan
    Yan, Qin
    Zhou, Binhua
    Wan, Yiqian
    Ma, Lin
    Song, Hucan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) : 6490 - 6493
  • [42] Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors
    Wu, Jianlong
    Hu, Xuesen
    Ma, Lin
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2011, 26 (03) : 449 - 452
  • [43] Synthesis and biological evaluation of bergenin analogues as mushroom tyrosinase inhibitors
    Kashima, Yusei
    Miyazawa, Mitsuo
    ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (09) : 1533 - 1541
  • [44] Exploring Novel Pyridine Carboxamide Derivatives as Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile
    Naseer, Ayesha
    Osra, Faisal Abdulrhman
    Awan, Asia Naz
    Imran, Aqeel
    Hameed, Abdul
    Shah, Syed Adnan Ali
    Iqbal, Jamshed
    Zakaria, Zainul Amiruddin
    PHARMACEUTICALS, 2022, 15 (10)
  • [45] Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors
    Vontzalidou, Argyro
    Zoidis, Grigoris
    Chaita, Eliza
    Makropoulou, Maria
    Aligiannis, Nektarios
    Lambrinidis, George
    Mikros, Emmanuel
    Skaltsounis, Alexios-Leandros
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5523 - 5526
  • [46] DFT, Molecular Docking and ADME Studies of Thiazolidinones as Tyrosinase Inhibitors
    Arshad, Raqeeba
    Khan, Muhammad Asim
    Mutahir, Sadaf
    Hussain, Sufyan
    Al-Hazmi, Ghaferah H.
    Refat, Moamen S.
    POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (08) : 6750 - 6765
  • [47] Flavones as tyrosinase inhibitors: kinetic studies in vitro and in silico
    Arroo, Randolph R. J.
    Sari, Suat
    Barut, Burak
    Ozel, Arzu
    Ruparelia, Ketan C.
    Sohretoglu, Didem
    PHYTOCHEMICAL ANALYSIS, 2020, 31 (03) : 314 - 321
  • [48] Synthesis, antiproliferative, docking and DFT studies of benzimidazole derivatives as EGFR inhibitors
    Alzahrani, Hessah Abdullah
    Alam, Mohammad Mahboob
    Elhenawy, Ahmed A.
    Malebari, Azizah M.
    Nazreen, Syed
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1253
  • [49] Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase
    Ozil, Musa
    Emirik, Mustafa
    Belduz, Ali
    Ulker, Serdar
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5103 - 5114
  • [50] Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors
    Celik, Ismail
    Ayhan-Kilcigil, Gulgun
    Guven, Berna
    Kara, Zumra
    Gurkan-Alp, A. Selen
    Karayel, Arzu
    Onay-Besikci, Arzu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 173 : 240 - 249